Kaplan JR, Adams MR, Anthony MS, Morgan TM, Manuck SB, Clarkson TB. Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys. Arterioscler Thromb Vasc Biol. 1995 Dec;15(12):2094-100. doi: 10.1161/01.ATV.15.12.2094
Anthony MS, Clarkson TB, Weddle DL, Wolfe MS. Effects of soy protein phytoestrogens on cardiovascular risk. J Nutr. 1995 Mar;125(Suppl 3):803S-4S.
Williams JK, Anthony MS, Honoré EK, Herrington DM, Morgan TM, Register TC. Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vasc Biol. 1995;15(7):827-36.
Kaplan JR, Clarkson TB, Adams MR, Anthony MS, Manuck SB, Morgan TM. Oral contraceptives inhibit atherogenesis in female monkeys at high risk due to social subordination. Circulation. 1995;92(Suppl I):I-627.
Brosnihan KB, Weddle D, Anthony MS, Heise CM, Ferrario CM. Chronic estrogen or estrogen and progestin replacement on the renin-angiotensin system in ovariectomized cynomolgus monkeys. FASEB J. 1995;9:A51.
Honoré EK, Williams JK, Anthony MS. Enhancement of coronary vasodilation by soy phytoestrogens. Circulation. 1995;92(Suppl I):I-349.
Anthony MS, Burke GL, Hughes CLJr, Clarkson TB. Does soy supplementation improve Coronary Heart Disease (CHD) risk? Presented at the 35th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, American Heart Association; March 1995. San Antonio, TX. [abstract] Circulation. 1995; 91:925.
Clarkson T, Anthony MS, Hughes C. Estrogenic soybean isoflavones and chronic disease: risks and benefits. Trends Endocrinol Metab. 1995 Jan;6(1):11-6.